Telephone: 5511-3091-7388; Fax: 5511-3091-7224
Tissue-Specific Stem Cells
Article first published online: 11 SEP 2009
Copyright © 2009 AlphaMed Press
Volume 27, Issue 12, pages 3063–3073, December 2009
How to Cite
Semedo, P., Correa-Costa, M., Antonio Cenedeze, M., Maria Avancini Costa Malheiros, D., Antonia dos Reis, M., Shimizu, M. H., Seguro, A. C., Pacheco-Silva, A. and Saraiva Ĉamara, N. O. (2009), Mesenchymal Stem Cells Attenuate Renal Fibrosis Through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney Model. STEM CELLS, 27: 3063–3073. doi: 10.1002/stem.214
Author contributions: P.S.: conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of manuscript; M.C.-C. and M.A.C.: collection and/or assembly of data, final approval of manuscript; D.M.A.C.M. and M.A.R.: histological analyses, data analysis and interpretation, final approval of manuscript; M.H.S. and A.C.S.: provision of study material, final approval of manuscript; A.P.-S.: administrative support, final approval of manuscript; N.O.S.C.: conception and design, data analysis and interpretation, financial support, final approval of manuscript.
First published online in STEM CELLS EXPRESS August 21, 2009.
Disclosure of potential conflicts of interest is found at the end of this article.
- Issue published online: 14 DEC 2009
- Article first published online: 11 SEP 2009
- Accepted manuscript online: 11 SEP 2009 12:00AM EST
- Manuscript Accepted: 21 AUG 2009
- Manuscript Received: 6 APR 2009
- State of Sao Paulo Foundation for Research Support (FAPESP). Grant Numbers: 04/08226-9, 06/0620-5, 07/07139-3
- Brazilian Council of Scientific and Technologic Development. Grant Numbers: 573815/2008-9-CNPq, MS/DECIT
- 1World Kidney Day: an idea whose time has come. Am J Kidney Dis 2006; 47: 375–377., , , et al.
- 2The Third World Kidney Day: looking back and thinking forward. Am J Kidney Dis 2008; 51: 349–352., .
- 3A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 1975; 79: 95–106., .
- 4Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85–F93., , , et al.
- 5Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996; 49: 666–678., , , et al.
- 6Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448–1456., .
- 7Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290–301..
- 8Pathways to nephron loss starting from glomerular diseases—insights from animal models. Kidney Int 2005; 67: 404–419., .
- 9Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 2007; 22: 2011–2022..
- 10Mechanisms underlying renoprotection during renin-angiotensin system blockade. Am J Physiol Renal Physiol 2001; 280: F343–355., , , et al.
- 11Focal glomerulosclerosis in the remnant kidney model—an inflammatory disease mediated by cytokines. Nephrol Dial Transplant 1997; 12: 430–437., .
- 12Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000; 58: 1664–1676., , , et al.
- 13Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 1999; 55: 945–955., , , et al.
- 14Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F315– F321., , , et al.
- 15Renal stem cells in recovery from acute kidney injury. Minerva Urol Nefrol 2006; 58: 329–337., , .
- 16Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008; 59: 311–325., .
- 17Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 2005; 68: 1956–1961., .
- 18Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant Proc 2007; 39: 421–423., , , et al.
- 19Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol 2009; 9: 677–682., , , et al.
- 20Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007; 292: F1626–F1635., , , et al.
- 21The role of bone marrow-derived cells in fibrosis. Cells Tissues Organs 2008; 188: 178–188., , .
- 22A forgotten method to induce experimental chronic renal failure in the rat by ligation of the renal parenchyma. Nephron Exp Nephrol 2006; 103: e126–e130., , , et al.
- 23The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis. J Hypertens 1993; 11: 969–975., , .
- 24Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats—influence of sex, strain, and surgical procedure. Exp Toxicol Pathol 2006; 57: 195–205., , , et al.
- 25Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1. Kidney Int 1999; 56: 1423–1431., , , et al.
- 26Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 2006; 290: R861–R870., , .
- 27Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 1971; 11: 345–349., , .
- 28Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726–736., , .
- 29Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 2008; 17: 1103–1113., .
- 30Mesenchymal stem cells for the treatment of heart failure. Int J Hematol 2007; 86: 17–21., , , et al.
- 31Therapeutic potential of bone marrow stem cells for liver diseases. Curr Stem Cell Res Ther 2006; 1: 411–418., , , et al.
- 32Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002; 99: 2199–2204., , , et al.
- 33Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 2008; 5: 637–667., , , et al.
- 34Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant Proc 2008; 40: 853–855., , , et al.
- 35The role of mesenchymal stem cells in the functional improvement of the chronic renal failure. Stem Cells Dev 2009; 18: 521–529., , , et al.
- 36Participation of bone marrow cells in biliary fibrosis after bile duct ligation. J Gastroenterol Hepatol 2007; 22: 2001–2008., , , et al.
- 37The bone marrow leaves its scar: new concepts in pulmonary fibrosis. J Clin Invest 2004; 113: 180–182., .
- 38Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617–1627., , , et al.
- 39Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 2009; 94: 258–263., , , et al.
- 40Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007; 257: 143–179., .
- 41Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005; 13: 7–12., , .
- 42Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells 2009; 27: 682–692., , , et al.
- 43Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 1998; 54: 1510–1519., , , et al.
- 44The inflammatory component in progressive renal disease–are interventions possible? Nephrol Dial Transplant 2002; 17: 363–368., , .
- 45The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420–1428., .
- 46EMT and proteinuria as progression factors. Kidney Int 2009; 75: 475–481..
- 47Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810–3820., , , et al.
- 48Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells 2009 [Epub ahead of print]., , , et al.
- 49Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115: 1743–1755., , , et al.
- 50Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001; 345: 93–97., , , et al.
- 51Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509–525., .
- 52Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838– 3843., , , et al.
- 53Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int 2008; 21: 1181–1189., , , et al.
- 54Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006; 70: 121–129., , , et al.
- 55Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int 2004; 65: 409–419., , , et al.
- 56Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 2002; 62: 1238–1248., , , et al.
- 57Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2003; 284: F349–F357., .
- 58Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice. Nephron Physiol 2006; 102:p 92–p102., , , et al.
- 59Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 2004; 53: 1119–1127., , , et al.
- 60Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 2005; 38: 426–435., .
- 61Heme oxygenase and renal disease. Curr Hypertens Rep 2009; 11: 56–62., .
- 62Heme oxygenase-1 is an essential cytoprotective component in oxidative tissue injury induced by hemorrhagic shock. J Clin Biochem Nutr 2009; 44: 28–40., , , et al.